CA Stock MarketDetailed Quotes
MOOD Doseology Sciences Inc
- 0.325
- +0.255+364.29%
15min DelayMarket Closed Jul 16 09:54 ET
1.43MMarket Cap-1300P/E (TTM)
0.325High0.325Low1.00KVolume0.325Open0.070Pre Close325.00Turnover0.66052wk High0.02%Turnover Ratio4.40MShares0.05052wk Low-0.25EPS TTM1.37MFloat Cap4.000Historical HighLossP/E (Static)4.23MShs Float0.050Historical Low-0.4EPS LYR0.00%Amplitude--Dividend TTM1.25P/B1Lot Size--Div YieldTTM
Doseology Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 69.45%-29.32K | -1,288.08%-131.17K | 75.90%-58.89K | 71.89%-481.05K | 59.03%-131.33K | 73.47%-95.96K | 97.83%-9.45K | 58.85%-244.32K | 27.74%-1.71M | 32.65%-320.52K |
| Net income from continuing operations | 63.34%-40.54K | 39.27%-111.64K | 77.04%-78.09K | 8.14%-1.78M | -109.35%-1.15M | 79.43%-110.56K | 66.16%-183.85K | -9.46%-340.07K | -19.23%-1.94M | 13.08%-547.9K |
| Operating gains losses | ---- | ---- | ---- | 9,880.02%252.79K | --247K | ---- | ---- | ---- | 142.22%2.53K | --0 |
| Depreciation and amortization | -97.15%797 | -97.16%797 | -36.45%17.98K | -52.63%66.09K | -165.91%-18.24K | -17.85%27.98K | -40.32%28.07K | -8.06%28.29K | 50.30%139.53K | -16.99%27.68K |
| Asset impairment expenditure | ---- | ---- | ---- | -94.03%12.45K | ---- | ---- | ---- | ---- | --208.67K | ---- |
| Remuneration paid in stock | --7.44K | 458.37%50.33K | -25.07%10.76K | -2.94%83.4K | 243.47%60.03K | --0 | -76.67%9.01K | -37.62%14.36K | 333.31%85.93K | -11.87%17.48K |
| Other non cashItems | --0 | ---- | ---- | 888.68%749.17K | 3,572.20%694.49K | -0.73%17.71K | -16.70%18.23K | 9.35%18.73K | 10.95%75.77K | 10.26%18.91K |
| Change In working capital | 108.08%2.98K | -143.56%-51.88K | -127.77%-9.54K | 148.05%136.58K | 144.13%20.01K | -131.50%-36.88K | 5,928.93%119.09K | 109.71%34.37K | 68.99%-284.27K | -153.92%-45.35K |
| -Change in receivables | -241.31%-12.57K | -61.16%25.39K | -3,839.22%-9.14K | 220.01%68.31K | 68.53%-5.72K | 438.95%8.9K | 311.87%65.37K | 97.57%-232 | -99.81%-56.92K | 31.37%-18.18K |
| -Change in inventory | 582.64%17.78K | -825.27%-45.41K | 321.66%6.44K | 104.67%1.8K | -280.41%-8.59K | 43.39%2.6K | 117.88%6.26K | 115.02%1.53K | 70.12%-38.62K | 476,300.00%4.76K |
| -Change in prepaid assets | -100.01%-4 | -60.96%16.05K | -117.51%-11.07K | 53.66%142.96K | 164.04%4.23K | -44.06%34.38K | -24.40%41.1K | 490.74%63.24K | 108.56%93.04K | 77.87%-6.61K |
| -Change in payables and accrued expense | 97.32%-2.22K | -853.95%-47.91K | 114.01%4.23K | 72.85%-76.49K | 218.84%30.09K | -258.66%-82.77K | -32.85%6.35K | 90.52%-30.17K | -185.82%-281.77K | -118.03%-25.32K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 69.45%-29.32K | -1,288.08%-131.17K | 75.90%-58.89K | 71.89%-481.05K | 59.03%-131.33K | 73.47%-95.96K | 97.83%-9.45K | 58.85%-244.32K | 27.74%-1.71M | 32.65%-320.52K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69.78%-7.88K | 87.82%-1.75K |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 95.79%-6.13K | --0 |
| Net intangibles purchas and sale | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 92.88%-1.75K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 69.78%-7.88K | 87.82%-1.75K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 124.34%8.54K | 75.35%-8.54K | 34.41%-91.88K | 156.55%19.46K | -44.79%-41.63K | 47.28%-35.08K | -233.86%-34.64K | -102.42%-140.08K | -111.59%-34.42K |
| Net issuance payments of debt | --0 | 124.34%8.54K | 75.35%-8.54K | 23.62%-91.88K | 154.37%18.71K | -42.18%-40.88K | -5.87%-35.08K | -44.33%-34.64K | -100.51%-120.3K | -129.45%-34.42K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 80.17%-19.78K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 124.34%8.54K | 75.35%-8.54K | 34.41%-91.88K | 156.55%19.46K | -44.79%-41.63K | 47.28%-35.08K | -233.86%-34.64K | -102.42%-140.08K | -111.59%-34.42K |
| Net cash flow | ||||||||||
| Beginning cash position | -28.34%1.11M | -22.65%1.23M | -30.57%1.3M | -49.79%1.87M | -36.65%1.41M | -40.84%1.55M | -48.99%1.6M | -49.79%1.87M | 995.21%3.73M | -43.18%2.23M |
| Current changes in cash | 78.69%-29.32K | -175.40%-122.64K | 75.83%-67.43K | 69.18%-572.94K | 68.64%-111.86K | 64.76%-137.59K | 91.20%-44.53K | 53.95%-278.96K | -154.80%-1.86M | -84.58%-356.68K |
| End cash Position | -23.44%1.08M | -28.34%1.11M | -22.65%1.23M | -30.57%1.3M | -30.57%1.3M | -36.65%1.41M | -40.84%1.55M | -48.99%1.6M | -49.79%1.87M | -49.79%1.87M |
| Free cash from | 69.45%-29.32K | -1,288.08%-131.17K | 75.90%-58.89K | 72.02%-481.05K | 59.25%-131.33K | 73.47%-95.96K | 97.85%-9.45K | 58.97%-244.32K | 32.28%-1.72M | 34.26%-322.26K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg